$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Fatty acid composition 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/20
출원번호 US-0471200 (1995-06-06)
우선권정보 GB-0019110 (1988-08-11)
발명자 / 주소
  • Breivik Harald (Skjelsvik NOX) Brretzen Bernt (Porsgrunn NOX) Dahl Knut Helks (Ulefoss NOX) Krokan Hans Einar (Sjetnemarka NOX) Bnaa Kaare Harald (Troms NOX)
출원인 / 주소
  • Norsk Hydro as (Oslo NOX 03)
인용정보 피인용 횟수 : 136  인용 특허 : 0

초록

Fatty acid composition comprising at least 80% by weight of omega-3-fatty acids, salts or derivatives thereof, wherein (all-Z)-5,8,11,14,17-eicosapentaenoic acid (EPA) and (all-Z)-4,7,10,13,16,19-docosahexaenoic acid comprises at least 75% by weight of the total fatty acids. The compositions can be

대표청구항

A method for elevating the HDL cholesterol level in the serum of a human patient, which comprises administering to the patient a pharmaceutical composition in which the active ingredients consist essentially of a mixture of fatty acids of which at least 80% by weight is comprised of a combination of

이 특허를 인용한 특허 (136)

  1. Bryhn, Morten; Holmeide, Anne Kristin; Rosman, Jenny, Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR).
  2. Wang Jaw-Kai, Antibacterially active extracts from the marine algae chaetoceros and methods of use.
  3. Gandhi,Neena, Antioxidant triacylglycerols and lipid compositions.
  4. Nicoud, Roger-Marc; Bléhaut, Jean, Chromatographic method for the production of polyunsaturated fatty acids.
  5. Adam, Philippe; Valéry, Eric; Bléhaut, Jean, Chromatographic process for the production of highly purified polyunsaturated fatty acids.
  6. Adam, Philippe; Valéry, Eric; Bléhaut, Jean, Chromatographic process for the production of highly purified polyunsaturated fatty acids.
  7. Rice, David; Parsheh, Mehran; Smith, Jordan; Radaelli, Guido, Clarification of suspensions.
  8. Fawzy, Abdel; Bobotas, George, Coating capsules with active pharmaceutical ingredients.
  9. Yokoyama, Mitsuhiro; Origasa, Hideki; Matsuzaki, Masunori; Matsuzawa, Yuji; Saito, Yasushi, Composition for preventing the occurrence of cardiovascular event in multiple risk patient.
  10. Yokoyama, Mitsuhiro; Origasa, Hideki; Matsuzaki, Masunori; Matsuzawa, Yuji; Saito, Yasushi, Composition for preventing the occurrence of cardiovascular event in multiple risk patient.
  11. Yokoyama, Mitsuhiro; Origasa, Hideki; Matsuzaki, Masunori; Matsuzawa, Yuji; Saito, Yasushi, Composition for preventing the occurrence of cardiovascular event in multiple risk patient.
  12. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject.
  13. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides.
  14. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy.
  15. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy.
  16. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
  17. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
  18. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
  19. Finley, Jahahreeh, Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation.
  20. Zakrzewski, Joseph S., Compositions and methods for treating or preventing obesity in a subject in need thereof.
  21. Zakrzewski, Joseph S., Compositions and methods for treating or preventing obesity in a subject in need thereof.
  22. Astwood, James; Collins, Michelle L.; Connolly, Brian, Compositions and methods for utilization of algal compounds.
  23. Zakrzewski, Joseph S., Compositions comprising EPA and obeticholic acid and methods of use thereof.
  24. Hustvedt, Svein Olaf; Olesen, Preben Houlberg; Berge, Gunnar; Mullertz, Anette, Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof.
  25. Hustvedt, Svein Olaf; Olesen, Preben Houlberg; Berge, Gunnar; Müllertz, Anette, Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof.
  26. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof.
  27. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof.
  28. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof.
  29. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof.
  30. Bryhn, Morten; Kopecky, Jan; Holmeide, Anne Kristin, Compounds.
  31. Bryhn, Morten; Kopecky, Jan; Holmeide, Anne Kristin, Compounds.
  32. Bryhn, Morten; Kopecky, Jan; Holmeide, Anne Kristin, Compounds.
  33. Maines, Timothy J.; Machielse, Bernardus N.; Mehta, Bharat M.; Wisler, Gerald L.; Davidson, Michael H.; Wood, Peter Ralph, DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form.
  34. Zhang, Peijin; Fatmi, Aqeel A., Enhanced bioavailability of polyunsaturated fatty acids.
  35. Zhang, Peijin; Fatmi, Aqeel A., Enhanced bioavailability of polyunsaturated fatty acids.
  36. Zhang, Peijin; Fatmi, Aqeel A., Enteric soft capsules comprising polyunsaturated fatty acids.
  37. Zhang, Peijin; Fatmi, Aqeel A., Enteric soft capsules comprising polyunsaturated fatty acids.
  38. Pamparana,Franco, Essential fatty acids in the prevention of cardiovascular events.
  39. Gallois-Bernos, Annabelle, Esters for treatment of ocular inflammatory conditions.
  40. Connor, Daniel Stedman; Scheibel, Jeffrey John; Back, Deborah Jean; Trinh, Toan; Vinson, Phillip Kyle; Severson, Roland George; Cripe, Thomas Anthony; Burckett-St. Laurent, James Charles Theophile Ro, Fatty acids, soaps surfactant systems, and consumer products based thereon.
  41. Connor, Daniel Stedman; Scheibel, Jeffrey John; Back, Deborah Jean; Trinh, Toan; Vinson, Phillip Kyle; Severson, Roland George; Cripe, Thomas Anthony; Burckett-St. Laurent, James Charles Theophile Ro, Fatty acids, soaps, surfactant systems, and consumer products based thereon.
  42. Connor,Daniel Stedman; Scheibel,Jeffrey John; Back,Deborah Jean; Trinh,Toan; Vinson,Phillip Kyle; Severson,Roland George; Cripe,Thomas Anthony; Burckett St. Laurent,James Charles Theophile Roger; Siv, Fatty acids, soaps, surfactant systems, and consumer products based thereon.
  43. Trinh, Toan; Sivik, Mark Robert; Wahl, Errol Hoffman; Frankenbach, Gayle Marie; Declercq, Marc Johan; Demeyere, Hugo Jean Marie, Fatty acids, soaps, surfactant systems, and consumer products based thereon.
  44. Opheim, Joar, Flavored gelatin capsule and method of manufacture.
  45. Opheim, Joar, Flavored vegetable starch capsule.
  46. Kelliher, Adam; Morrison, Angus; Oroskar, Anil; Nair Rema, Rakesh Vikraman; Agarwal, Abhilesh, Heated chromatographic separation process.
  47. Kelliher, Adam; Morrison, Angus; Oroskar, Anil; Nair Rema, Rakesh Vikraman; Agarwal, Abhilesh, Heated chromatographic separation process.
  48. Mustad, Vikkie A.; DeMichele, Stephen; Zinker, Bradley A.; Huang, Yung Sheng, Lipid system and methods of use.
  49. Mustad, Vikkie A.; DeMichele, Stephen; Zinker, Bradley A.; Huang, Yung-Sheng, Lipid system and methods of use.
  50. Cravotto, Giancarlo, Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field.
  51. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
  52. Bobotas, George; Fawzy, Abdel Aziz, Methods of administering compositions comprising docosapentaenoic acid.
  53. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Zakrzewski, Joseph S., Methods of reducing apolipoprotein C-III.
  54. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Zakrzewski, Joseph S., Methods of reducing apolipoprotein C-III.
  55. Mason, Richard Preston, Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids.
  56. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  57. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  58. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  59. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  60. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  61. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  62. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  63. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  64. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  65. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  66. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  67. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  68. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  69. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  70. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  71. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  72. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  73. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  74. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  75. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  76. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  77. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  78. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  79. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  80. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Breackman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  81. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
  82. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
  83. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
  84. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
  85. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
  86. Kelliher, Adam; Morrison, Angus, Multi-step separation process.
  87. Kelliher, Adam; Morrison, Angus, Multi-step separation process.
  88. Kelliher, Adam; Morrison, Angus, Multi-step separation process.
  89. Miller, Raymond A., Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline.
  90. Feuerstein, Seth; Coric, Ann; Sanfilippo, Louis C., Omega 3 fatty acid formulations.
  91. Hoem, Nils; Burri, Lena; Berge, Kjetil, Omega-3 compositions.
  92. Sandnes, Olav; Miller, Bruce A.; Dyerberg, Jorn, Omega-3 compositions, dosage forms, and methods of use.
  93. Sandnes, Olav; Miller, Bruce A.; Dyerberg, Jorn, Omega-3 compositions, dosage forms, and methods of use.
  94. Sandnes, Olav; Miller, Bruce A.; Dyerberg, Jorn; Stender, Steen, Omega-3 compositions, dosage forms, and methods of use.
  95. Bobotas, George; Fawzy, Abdel Aziz, Omega-3 pentaenoic acid compositions and methods of use.
  96. Breivik, Harald; Thorstad, Olav, Pharmaceutical composition comprising low concentrations of environmental pollutants.
  97. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Pharmaceutical compositions comprising fatty acids.
  98. Breivik, Harald; Thorstad, Olav, Process for decreasing environmental pollutants in an oil or a fat.
  99. Sondbø, Sverre; Thorstad, Olav, Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid.
  100. Kelliher, Adam; Morrison, Angus; Oroskar, Anil; Nair Rema, Rakesh Vikraman; Agarwal, Abhilesh, SMB process.
  101. Kelliher, Adam; Morrison, Angus; Oroskar, Anil; Nair Rema, Rakesh Vikraman; Agarwal, Abhilesh, SMB process.
  102. Kelliher, Adam; Morrison, Angus; Oroskar, Anil; Nair Rema, Rakesh Vikraman; Agarwal, Abhilesh, SMB process.
  103. Kelliher, Adam; Morrison, Angus; Oroskar, Anil; Nair Rema, Rakesh Vikraman; Agarwal, Abhilesh, SMB process for producing highly pure EPA from fish oil.
  104. Kelliher, Adam; Morrison, Angus; Oroskar, Anil; Nair Rema, Rakesh Vikraman; Agarwal, Abhilesh, SMB process for producing highly pure EPA from fish oil.
  105. Cowen, Neil M.; Pasternak, Richard C., Salts of potassium ATP channel openers and uses thereof.
  106. Kelliher, Adam; Morrison, Angus; Oroskar, Anil; Nair Rema, Rakesh Vikraman; Agarwal, Abhilesh, Simulated moving bed chromatographic separation process.
  107. Kelliher, Adam; Morrison, Angus; Oroskar, Anil; Nair Rema, Rakesh Vikraman; Agarwal, Abhilesh, Simulated moving bed chromatographic separation process.
  108. Kelliher, Adam; Morrison, Angus; Oroskar, Anil; Nair Rema, Rakesh Vikraman; Agarwal, Abhilesh, Simulated moving bed chromatographic separation process.
  109. Breivik, Harald; Sanna, Lola Irene, Stabilization of pigments and polyunsaturated oils.
  110. Manku, Mehar, Stable pharmaceutical composition and methods of using same.
  111. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  112. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  113. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  114. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  115. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  116. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  117. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  118. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  119. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  120. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  121. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  122. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  123. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  124. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  125. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  126. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  127. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  128. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  129. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  130. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  131. Fleischer, Daniel, Systems and methods for utilizing and recovering chitosan to process biological material.
  132. Calder, Philip; Grimble, Robert; Gallagher, Patrick; Shearman, Cliff, Use of EPA and DHA in secondary prevention.
  133. Bryhn, Morten; Kopecky, Jan, Use of a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof.
  134. Shibuya, Hajime, Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events.
  135. Shibuya, Hajime, Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events.
  136. Shibuya, Hajime, Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로